#elililly

32-34 NEW PHARMA - In therapies PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat...

6 days ago

#obesity #diabetes #typeIIdiabetes #oncology #neurology #rarediseases #womenshealth #EliLilly #Akeso #SummitTherapeutics #precisionmedicine #immunotherapy #Alzheimersdisease #AstraZeneca #DaiichiSankyo #ADCs #precisiononcology #DrugstoWatch2026 #immunology #cardiology #CGTs
zurl.co/c8PJw

5 0 1 0

Investičníweb.cz :bot:

@investicniweb.zpravobot.news.ap.brid.gy

1 week ago

Dřív nuda, teď jízda: #Léky na #hubnutí mění farmaceutický sektor k nepoznání www.investicniweb.cz/akcie-svet/318887-farmac... #farmacie #zdravotnictví #EliLilly #NovoNordisk

0 0 0 0

Lilly unveils employer scheme for weight-loss drug Zepbound Eli Lilly has added another channel to its selling options for obesity therapy Zepbound in the US, launching a programme directed at employers.

1 week ago

#EliLilly has added another channel to its selling options for obesity therapy #Zepbound in the #US, launching a programme directed at #employers.

pharmaphorum.com/news/lilly-u...

0 0 0 0

Orforglipron orale supera semaglutide in controllo glicemico e perdita di peso SESTO FIORENTINO (ITALPRESS) – Eli Lilly and Company ha annunciato oggi i risultati dettagliati di ACHIEVE-3, il primo studio di Fase 3 testa-a-testa che ha valutato sicurezza ed efficacia di orforglipron, una piccola molecola ...

1 week ago

In a move that will delight #NovoNordisk and #EliLilly, the #FDA has sent #warningletters to 30 #telehealth companies, accusing them of #illegallymarketing #compounded #GLP1 agonist formulations.

buff.ly/GbfCB89

0 0 0 0

ilQuaderno.it

@ilquaderno.bsky.social

2 weeks ago

TI POTREBBE INTERESSARE: Orforglipron orale supera semaglutide in controllo glicemico e perdita di peso ... LEGGI TUTTO #Orforglipron #Semaglutide #ControlloGlicemico #PerditaDiPeso #EliLilly

0 0 0 0

ilQuaderno.it

@ilquaderno.bsky.social

2 weeks ago

Orforglipron orale supera semaglutide in controllo glicemico e perdita di peso SESTO FIORENTINO (ITALPRESS) – Eli Lilly and Company ha annunciato oggi i risultati dettagliati di ACHIEVE-3, il primo studio di Fase 3 testa-a-testa che ha valutato sicurezza ed efficacia di orforglipron, una piccola molecola ...

È ACCADUTO IERI: Orforglipron orale supera semaglutide in controllo glicemico e perdita di peso ... LEGGI TUTTO #Orforglipron #Semaglutide #ControlloGlicemico #PerditaDiPeso #EliLilly

0 0 0 0

@pharmalot.bsky.social

2 weeks ago

Pharmalittle: We're reading about a puzzling FDA rejection, a Lilly weight loss pill, and more An experimental therapy for a rare blood cancer was rejected by the FDA though internal reviewers had recommended it be cleared

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a puzzling FDA rejection, a Lilly weight loss pill, and more news.. statnews.com/pharmalot/20... #pharma #FDA #obesity #weightloss #HIV #Gilead #Sarepta #EliLilly

1 0 1 0

The Pharmaceutical Journal

@pharmaj.bsky.social

2 weeks ago

Orforglipron offers greater weight loss for people with diabetes than oral semaglutide Novel weight-loss pill orforglipron (Emgality; Eli Lilly) offers patients with type 2 diabetes mellitus (T2DM) better blood sugar control and more weight loss than semaglutide — the only other GLP-1…

Patients with #type2diabetes taking weight-loss pill #orforglipron achieved better blood sugar control and more weight loss than those on #semaglutide in pill form, research shows

#weightloss #Emgality #EliLilly #diabetesmellitus #T2DM

buff.ly/vRMS2ir

0 0 0 0

ilQuaderno.it

@ilquaderno.bsky.social

2 weeks ago

Orforglipron orale supera semaglutide in controllo glicemico e perdita di peso SESTO FIORENTINO (ITALPRESS) – Eli Lilly and Company ha annunciato oggi i risultati dettagliati di ACHIEVE-3, il primo studio di Fase 3 testa-a-testa che ha valutato sicurezza ed efficacia di orforglipron, una piccola molecola ...

Orforglipron orale supera semaglutide in controllo glicemico e perdita di peso ... LEGGI TUTTO #Orforglipron #Semaglutide #ControlloGlicemico #PerditaDiPeso #EliLilly

0 0 0 0

Astellas bets on Vir cancer drug, and other licensing deals Our latest round-up of pharma licensing deals features assets from Vir Biotech, Harbour BioMed, Unnatural Products, Genhouse, and CSL.

2 weeks ago

#pharmalicensingdeals #pharmaceuticalassets #VirBiotech #Vir #HarbourBioMed #UnnaturalProducts #Genhouse #CSL #Astellas #SolsticeOncology #antiCTLA4antibody #Novartis #UnnaturalProducts #macrocyclicpeptidedrugs #GileadSciences #syntheticlethality #GenhouseBio #Arcellx #EliLilly
zurl.co/HOdjt

0 0 0 0

News Mason

@newsmason.bsky.social

3 weeks ago

#trends today for 'brock lesnar' 'susan rice' & 'eli lilly'

Click/Tap below:

www.newsmason.com?query=%22bro...

www.newsmason.com?query=%22sus...

www.newsmason.com?query=%22eli...

#brocklesnar #susanrice #elililly

0 0 0 0

@pharmalot.bsky.social

3 weeks ago

Pharmalittle: We're reading about pharma lobbying, a disappointing Novo clinical trial, and much more Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more news.. statnews.com/pharmalot/20... #pharma #lobbying #obesity #tariffs #generics #Gilead #Merck #novonordisk #EliLilly

0 1 0 0

Negocios TV

@negociostv.bsky.social

3 weeks ago

¿Por qué Novo Nordisk cae un 16%? Esta es la razón por la que pierde terreno frente a Eli Lilly

https://youtu.be/cUvNDh_dzzE

#novonordisk #caida #elililly #mercados #bolsa #obesidad #farmacos #market #breakingnews #ozempic #wegovy #economia #negociostv

0 0 0 0

Negocios TV

@negociostv.bsky.social

3 weeks ago

¿Por qué Novo Nordisk cae un 16%? Esta es la razón por la que pierde terreno frente a Eli Lilly

https://youtu.be/cUvNDh_dzzE

#novonordisk #caida #elililly #mercados #bolsa #obesidad #farmacos #market #breakingnews #ozempic #wegovy #economia #negociostv

0 0 0 0

Don Porqué

@donporque.bsky.social

3 weeks ago

¿Qué falló en CagriSema y hundió a Novo Nordisk en Bolsa? Novo Nordisk se hunde en Bolsa por CagriSema: el ensayo clave frente a tirzepatida decepciona y refuerza a Eli Lilly, cifras y consecuencias. Novo Nordisk se dejó en el parqué una parte notable de su ...

¿Qué falló en CagriSema y hundió a Novo Nordisk en Bolsa? #NovoNordisk #EliLilly #CagriSema #Tirzepatida #Wegovy #Ozempic #Zepbound #Mounjaro #Obesidad #Farmaceuticas #Bolsa #Mercados #23defebrero #felizlunes donporque.com/novo-nordisk...

0 0 0 0

Roche claims midstage win for obesity injectable Roche reports weight loss of up to 22.5% with its injectable GIP/GLP-1 agonist obesity drug, setting up phase 3, but will it be too late to the table?

3 weeks ago

#weightloss #obesity #drugdevelopment #Roche #obesityinjectable #phase2results #dualGIPGLP1agonist #phase3programme #CT388 #CarmotTherapeutics #BMI #GLP1directedmedicines #EliLilly #GIPGLP1activity #NovoNordisk #GLP1drug #obesitycategory #IQVIA #ZealandPharma
zurl.co/nATCt

0 0 0 0

Industry Examiner

@industryexaminer.bsky.social

1 month ago

Lilly’s $2.4bn in-vivo CAR-T bet: can RNA turn cell therapy into a scalable drug? - Biotech Industry Examiner On February 9, Eli Lilly agreed to buy Orna Therapeutics for up to $2.4bn in cash, betting that one of biotech’s most powerful treatment ideas — CAR-T cell

CAR-T works. But it’s bespoke: collect cells, engineer, ship back — often 3–6 weeks. Lilly’s up-to-$2.4bn Orna deal bets on in-vivo CAR-T (circular RNA + LNPs) to make an autoimmune “immune reset” scalable. biotech.industryexaminer.com/lilly-orna-i...
#Biotech #CART #EliLilly #TechNews #BiotechNews

0 0 0 0

1 month ago

Chasing #NovoNordisk and #EliLilly, #Kailera and #Hengrui have reported 12.1% weight loss in phase 2 with their oral GIP/GLP-1 agonist ribupatide.

pharmaphorum.com/news/kailera...

0 0 0 0

Lilly strikes again, buying CAR-T firm Orna for $2.4bn In its second major deal in two days, Eli Lilly has reached an agreement to buy in vivo CAR-T developer Orna Therapeutics for up to $2.4bn.

1 month ago

#EliLilly has signed its second pipeline-building deal in two days, reaching an #agreement to buy #invivo #CART developer #OrnaTherapeutics for up to $2.4 billion.

0 0 0 0

Lilly strikes $8.8bn-plus alliance with China's Innovent Eli Lilly has deepened its ties with Chinese biopharma company Innovent Biologics, signing a seventh R&D with a $350m upfront payment.

1 month ago

#EliLilly has deepened its ties with #Chinesebiopharma company #InnoventBiologics, signing a seventh R&D #collaboration that includes a $350 million upfront payment.

pharmaphorum.com/news/lilly-s...

0 0 0 0

Fortune Turkey

@fortuneturkey.bsky.social

1 month ago

3) 8,5 milyar dolara kadar dönüm noktası ödemelerine ve satışlara bağlı kademeli telif gelirlerine hak kazanacak. Şirket, bu ortaklığın yalnızca lisanslama değil, ortak ilaç geliştirmeye dayalı kapsamlı bir inovasyon modeli sunduğunu belirtti. #InnoventBiologics #EliLilly

0 0 0 0

J&J bets on Isomorphic for AI-powered drug hunt Isomorphic Labs has added Johnson & Johnson to the roster of pharma companies tapping into its AI-based drug discovery engine

1 month ago

#JnJ #Isomorphic #Alphabet #IsomorphicLabs #pharmacompanies #AIbaseddrugdiscovery #researchcollaboration #drugdevelopment #EliLilly #Novartis #smallmoleculetherapeutics #largemoleculetherapeutics #biologics #AIdrivendrugdesign #DeepMind #AlphaFold #proteinfolding
zurl.co/dBpBC

0 0 0 0

News Mason

@newsmason.bsky.social

1 month ago

#trends today for 'eli lilly' 'world factbook reference' & 'cia ends'

Click/Tap below:

www.newsmason.com?query=%22eli...

www.newsmason.com?query=%22wor...

www.newsmason.com?query=%22cia...

#elililly #worldfactbookreference #ciaends

0 0 0 0